Literature DB >> 30698756

Clinical significance of Janus Kinase inhibitor selectivity.

Ernest H Choy1.   

Abstract

Entities:  

Year:  2019        PMID： 30698756      PMCID： PMC6532441          DOI： 10.1093/rheumatology/kez002

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
Rheumatology 2019;58:953–62. doi:10.1093/rheumatology/key339 In Table 3, the entry in the ‘DVT/PE’ row, first column ‘Tofacitinib (JAK, JAK3)’ has been replaced with ‘NR’ as it states later in the paper that this is not reported.
  5 in total

1.  Influence of Janus Kinase Inhibitors on the Neuronal Activity as a Proof-of-Concept Model for Itch.

Authors:  Johannes Wohlrab; David Stintzing; Luise Schultz; Konstantin Jügelt; Olaf H-U Schroeder
Journal:  Skin Pharmacol Physiol       Date:  2021-09-16       Impact factor: 3.479

2.  Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways.

Authors:  Yu Zhou; Xin Li; Ru Shen; Xiangzhu Wang; Fan Zhang; Suxing Liu; Di Li; Jian Liu; Puhui Li; Yinfa Yan; Ping Dong; Zhigao Zhang; Heping Wu; Linghang Zhuang; Rasheduzzaman Chowdhury; Matthew Miller; Mena Issa; Yuchang Mao; Hongli Chen; Jun Feng; Jing Li; Chang Bai; Feng He; Weikang Tao
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

Review 3.  COVID-19: an Immunopathological View.

Authors:  Kamran Kadkhoda
Journal:  mSphere       Date:  2020-04-22       Impact factor: 4.389

4.  Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species.

Authors:  Rhiannon N Hardwick; Patrick Brassil; Ilaria Badagnani; Kimberly Perkins; Glenmar P Obedencio; Andrea S Kim; Michael W Conner; David L Bourdet; Eric B Harstad
Journal:  Toxicol Sci       Date:  2022-03-28       Impact factor: 4.849

Review 5.  Application of Baricitinib in Dermatology.

Authors:  Jingya Zhang; Fei Qi; Jie Dong; Yaqi Tan; Ling Gao; Fang Liu
Journal:  J Inflamm Res       Date:  2022-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.